Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients. (6th November 2014)

Record Type:
Journal Article
Title:
Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients. (6th November 2014)
Main Title:
Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
Authors:
Pico de Coaña, Yago
Poschke, Isabel
Yoshimoto, Yuya
Karlberg, Sara
Nyström, Maria
Wolodarski, Maria
Hansson, Johan
Masucci, Giuseppe
Kiessling, Rolf
Abstract:
Is Part Of:
Journal for immunotherapy of cancer. Volume 2(2014)Supplement 3
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Issue Display:
Volume 2, Issue 3 (2014)
Year:
2014
Volume:
2
Issue:
3
Issue Sort Value:
2014-0002-0003-0000
Page Start:
Page End:
Publication Date:
2014-11-06
Subjects:
Melanoma -- Ipilimumab -- Unresectable Stage -- Treg Frequency -- Pharmacodynamic Marker
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:
http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:
10.1186/2051-1426-2-S3-P231 ↗
Languages:
English
ISSNs:
2051-1426
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
19213.xml